Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep — Steamboat 2

Epileptic Encephalopathy Clinical Trial

Official title:
Long-Term, Open-Label Extension Study to Evaluate the Safety and Tolerability of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

Status Enrolling by invitation

Clinical Trial Summary

The primary objective for this study is to evaluate the long-term safety and tolerability of NBI-827104 in pediatric participants with epileptic encephalopathy with continuous spike-and-wave during sleep (EECSWS).

Clinical Trial Description

This study will enroll participants who completed treatment in the Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group Study NBI-827104-CSWS2010 (NCT04625101). Participants who did not participate in Study NBI-827104-CSWS2010 may also be eligible for enrollment. ;

Study Design

Related Conditions & MeSH terms

Brain Diseases
Continuous Spike and Wave During Sleep
Epilepsy
Epileptic Encephalopathy

Clinical Trial Details

NCT number	NCT05301894
Study type	Interventional
Source	Neurocrine Biosciences
Contact
Status	Enrolling by invitation
Phase	Phase 2
Start date	June 7, 2022
Completion date	February 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01858285` - Genetics of Epilepsy and Related Disorders
Recruiting	`NCT04802135` - Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
Terminated	`NCT03955432` - Long-term Cardiac Monitoring in Epilepsy	N/A
Recruiting	`NCT05722990` - Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam
Recruiting	`NCT02603991` - Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)	N/A
Recruiting	`NCT04496310` - Tele-epic (Telemedicine for Epilepsy Care)	N/A
Recruiting	`NCT03934268` - A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
Completed	`NCT04625101` - Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep	Phase 2
Active, not recruiting	`NCT03024827` - Cannabidiol in Children With Refractory Epileptic Encephalopathy	Phase 1
Active, not recruiting	`NCT03936777` - A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome	Phase 3